Capoten and Axid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Capoten (captopril) and Axid (nizatidine). Common drug interactions include coronary artery disease among females and adult respiratory distress syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Capoten and Axid. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Capoten?
Capoten has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 2,954 Capoten users. Check the latest studies of Capoten.
What is Axid?
Axid has active ingredients of nizatidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 2,980 Axid users. Check the latest studies of Axid.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
12 people who take Capoten and Axid together, and have interactions are studied.

What are the common drug interactions of Capoten and Axid, by gender? *:
female:
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Coronary artery thrombosis (clot formation in coronary artery)
- Cough
- Cystitis glandularis (forming a timorous lesion with blueberry spots in the urinary bladder)
- Deafness
- Decreased appetite
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Dehydration (dryness resulting from the removal of water)
- Depressed mood
- Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
male:
- Adult respiratory distress syndrome (type of lung (pulmonary) failure)
- Blood glucose increased
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Pleural effusion (water on the lungs)
- Respiratory distress (difficulty in breathing)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Weakness
- Pulmonary congestion (congestion in the lungs)
- Pyrexia (fever)
- Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
What are the common drug interactions of Capoten and Axid, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Coronary artery thrombosis (clot formation in coronary artery)
- Cough
- Cystitis glandularis (forming a timorous lesion with blueberry spots in the urinary bladder)
- Deafness
- Decreased appetite
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Dehydration (dryness resulting from the removal of water)
- Depressed mood
- Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
- Diabetes mellitus inadequate control
50-59:
n/a
60+:
- Blood glucose increased
- Bone marrow depression (decreased ability or inability of the bone marrow to produce blood cells)
- Pleural effusion (water on the lungs)
- Respiratory distress (difficulty in breathing)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Weakness
- Adult respiratory distress syndrome (type of lung (pulmonary) failure)
- Pulmonary congestion (congestion in the lungs)
- Pyrexia (fever)
- Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
What are the existing conditions these people have? *
- Pain: 3 people, 25.00%
- Heart Attack: 2 people, 16.67%
- Urinary Tract Infection: 1 person, 8.33%
- Constipation: 1 person, 8.33%
- Eye Irritation: 1 person, 8.33%
- Eye Infection: 1 person, 8.33%
- Enlarged Heart: 1 person, 8.33%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 8.33%
- Dyspnea (difficult or laboured breathing): 1 person, 8.33%
- Diarrhea: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Capoten and Axid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Capoten and Axid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Capoten:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Axid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Capoten and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Axid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on captopril and nizatidine (the active ingredients of Capoten and Axid, respectively), and Capoten and Axid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Aplastic Anemia and Hearing Loss - 5 seconds ago
- Could Lescol cause Haemoglobin Decreased? - 6 seconds ago
- Could Divalproex cause Diarrhea? - 9 seconds ago
- Could Divalproex cause Stools - Watery? - 9 seconds ago
- Could Omeprazole cause Device Occlusion? - 19 seconds ago
- Drug interactions of Hydralazine Hydrochloride and Miralax - 19 seconds ago
- Could Omeprazole cause Entero-Enteral Or Enterocutaneous Fistula? - 25 seconds ago
- Could Gemcitabine cause Cardiomyopathy? - 29 seconds ago
- Could Metformin Hydrochloride cause Platelet Count Abnormal? - 29 seconds ago
- Could Kytril cause Abscess Limb? - 30 seconds ago